The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $140.47

Today's change-2.31 -1.62%
Updated June 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $140.47

Today's change-2.31 -1.62%
Updated June 27 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc crosses below 20-day moving average

Abiomed Inc closed sharply lower Tuesday, dropping (U.S.)$2.31 or 1.62% to (U.S.)$140.47 and crossing below its 20-day moving average. Shares have lost 2.76% over the last five days, but sit 4.73% below their 52-week high. This security has outperformed the S&P 500 by 17.83% during the last year.

Key company metrics

  • Open(U.S.) $142.72
  • Previous close(U.S.) $142.78
  • High(U.S.) $142.72
  • Low(U.S.) $139.65
  • Bid / Ask(U.S.) $119.00 / (U.S.) $149.69
  • YTD % change+24.66%
  • Volume318,361
  • Average volume (10-day)258,528
  • Average volume (1-month)327,189
  • Average volume (3-month)305,947
  • 52-week range(U.S.) $95.14 to (U.S.) $147.45
  • Beta0.20
  • Trailing P/E120.91×
  • P/E 1 year forward77.78×
  • Forward PEG2.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.16
Updated June 27 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2017Q3/2017Q2/2017Q1/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue125115103103
Total other revenue--------
Total revenue125115103103
Gross profit105968688
Total cost of revenue19191715
Total operating expense96898882
Selling / general / administrative60545351
Research & development16161816
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income29251521
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax29261521
Income after tax1515913
Income tax, total141069
Net income1515913
Total adjustments to net income--------
Net income before extra. items1515913
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1515913
Inc. avail. to common incl. extra. items1515913
Diluted net income1515913
Dilution adjustment------0
Diluted weighted average shares45454545
Diluted EPS excluding extraordinary itemsvalue per share0.330.340.200.29
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.330.340.200.29